Analysts have set 12-month price targets for Jazz Pharmaceuticals, revealing an average target of $181.11, a high estimate of ...

Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex.

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 ...

Dave Ramsey has made a living dishing out advice on personal finance since the late 80s, but just how much has he managed to put away for himself in the process? Here’s what the pop-finance ...

Terming it a major milestone that will strengthen bilateral trade, investment, defence, and technology partnerships, the apex ...

As India prepares for pivotal discussions between Prime Minister Narendra Modi and US President Donald Trump in February 2025 ...

The Union Budget 2025 balances fiscal discipline with a strong push for demand-driven growth. It addresses economic ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...

Artelo Biosciences (ARTL) announced nonclinical results on ART12.11, its proprietary cocrystal composition of cannabidiol and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...

Lexaria Bioscience (LEXX) has been granted two new patents from the United States Patent and Trademark Office for the use of DehydraTECH ...